-
2023-508805-26-00
1
2024-10-23
patients with active brain metastases, where the primary tumour has co
-
2022-502825-17-00
4
2024-10-07
Melanoma
-
2023-507536-21-00
7
2024-10-04
Advanced Solid Tumors
-
2023-508304-38-00
4
2024-09-10
Ulcerative Colitis (UC)
-
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
-
2023-509606-30-00
5
2024-07-24
Ulcerative colitis
-
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
-
2023-503904-10-00
5
2024-06-07
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
-
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
-
2023-503545-67-00
5
2024-04-30
Tourette's Disorder
-
2023-503221-19-00
4
2024-04-18
Advanced Non-Small Cell Lung Cancer
-
2022-501606-35-01
11
2024-02-21
Platinum-sensitive epithelial ovarian, fallopian tube, or primary
peri
-
2023-505121-14-00
5
2024-01-18
Moderate to Severe Plaque Psoriasis
-
2023-503920-14-00
5
2024-01-02
Non-Small Cell Lung Cancer (NSCLC)
-
2022-501099-24-00
5
2023-12-22
Migraine
-
2022-502739-20-00
5
2023-11-16
Active Idiopathic Inflammatory Myopathies (Including Dermatomyositis o
-
2022-501100-94-00
5
2023-11-08
Episodic Migraine
-
2023-504247-13-00
4
2023-10-17
Large cell neuroendocrine carcinoma
-
2022-502548-12-00
5
2023-09-28
marginal zone lymphoma
-
2022-502959-54-00
5
2023-09-26
Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Ep
-
2022-501703-27-00
5
2023-07-05
Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
-
2022-501354-10-01
5
2023-06-21
axial spondyloarthritis
-
2023-504595-26-00
4
2023-05-22
Non-Small Cell Lung Cancer
-
2023-509335-60-00
1
2023-02-23
Advanced solid tumors including (but not limited to), non-small cell l